Novel 6-Methoxy-3,4-dihydro-1-isoquinoline Compounds for Treating Diabetes.
作者信息
Sabnis Ram W
机构信息
Smith, Gambrell & Russell LLP, 1105 West Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
出版信息
ACS Med Chem Lett. 2022 May 25;13(6):891-892. doi: 10.1021/acsmedchemlett.2c00220. eCollection 2022 Jun 9.
Abstract
摘要
相似文献
1
Novel 6-Methoxy-3,4-dihydro-1-isoquinoline Compounds for Treating Diabetes.用于治疗糖尿病的新型6-甲氧基-3,4-二氢-1-异喹啉化合物
ACS Med Chem Lett. 2022 May 25;13(6):891-892. doi: 10.1021/acsmedchemlett.2c00220. eCollection 2022 Jun 9.
2
Synthesis, radiosynthesis, and in vitro evaluation of [131I]-5-iodo-N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-yl)-ethyl]-2-methoxy-benzamide as a potential tumor imaging agent.[131I]-5-碘-N-[2-(6,7-二甲氧基-3,4-二氢-1H-异喹啉-2-基)乙基]-2-甲氧基苯甲酰胺作为一种潜在肿瘤显像剂的合成、放射性合成及体外评价
Appl Radiat Isot. 2009 Apr;67(4):594-7. doi: 10.1016/j.apradiso.2008.12.010. Epub 2008 Dec 24.
3
Novel Synthesis of 4-Benzylidene-2-((1-phenyl-3,4-dihydroisoquinoline-2(1H)-yl)methyl) oxazol-5(4H)-one Derivatives Using 1,2,3,Tetrahydroisoquinoline and their Antimicrobial Activity.新型 4-苄叉基-2-((1-苯基-3,4-二氢异喹啉-2(1H)-基)甲基)恶唑啉-5(4H)-酮衍生物的合成及抗菌活性研究。
Curr Org Synth. 2020;17(5):396-403. doi: 10.2174/1570179417666200415151228.
4
3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.3,4-二氢-2(1H)-喹啉酮作为一种新型抗抑郁药物：1-[3-[4-(3-氯苯基)-1-哌嗪基]丙基]-3,4-二氢-5-甲氧基-2(1H)-喹啉酮及其衍生物的合成与药理学
J Med Chem. 2000 Jan 27;43(2):177-89. doi: 10.1021/jm980333v.
5
Synthesis and murine antineoplastic activity of bis[(carbamoyloxy)methyl] derivatives of pyrrolo[2,1-a]isoquinoline.吡咯并[2,1-a]异喹啉的双[(氨甲酰氧基)甲基]衍生物的合成及其对小鼠的抗肿瘤活性
J Med Chem. 1984 Oct;27(10):1321-5. doi: 10.1021/jm00376a017.
6
[Synthesis of spiro(3-hydroxycyclopentane-1,4'-2'-3'-dihydro-6'-methoxy-2'-methyl-1'H-isoquinoline) (author's transl)].螺（3-羟基环戊烷-1,4'-2'-3'-二氢-6'-甲氧基-2'-甲基-1'H-异喹啉）的合成（作者译）
Yakugaku Zasshi. 1973 Oct;93(10):1371-7. doi: 10.1248/yakushi1947.93.10_1371.
7
Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors.新型7-甲氧基-6-恶唑-5-基-2,3-二氢-1H-喹唑啉-4-酮作为肌苷-5'-单磷酸脱氢酶（IMPDH）抑制剂
Bioorg Med Chem Lett. 2005 Dec 1;15(23):5335-9. doi: 10.1016/j.bmcl.2005.06.108. Epub 2005 Oct 3.
8
1H-2-benzopyran-1-one derivatives, microbial products with pharmacological activity. Relationship between structure and activity in 6-[[1(S)-(3(S),4- dihydro-8-hydroxy-1-oxo-1H-2-benzopyran-3-yl)-3-methylbutyl]-amino]-4(S), 5(S)-dihydroxy-6-oxo-3(S)-ammoniohexanoate.1H - 2 - 苯并吡喃 - 1 - 酮衍生物，具有药理活性的微生物产物。6 - [[1(S)-(3(S),4 - 二氢 - 8 - 羟基 - 1 - 氧代 - 1H - 2 - 苯并吡喃 - 3 - 基)-3 - 甲基丁基]-氨基]-4(S),5(S)-二羟基 - 6 - 氧代 - 3(S)-铵基己酸酯的结构与活性关系。
J Med Chem. 1983 Oct;26(10):1370-4. doi: 10.1021/jm00364a007.
9
Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.源自异喹啉-1,3-二酮的新型螺琥珀酰亚胺醛糖还原酶抑制剂：2-[(4-溴-2-氟苯基)甲基]-6-氟螺[异喹啉-4(1H),3'-吡咯烷]-1,2',3,5'(2H)-四酮及其类似物。1.
J Med Chem. 1994 Jun 24;37(13):2043-58. doi: 10.1021/jm00039a017.
10
Synthesis of an anti-inflammatory 10,10a-dihydro-1H,5H-imidazo[1,5-b)isoquinoline-1,3(2H)-dione.一种抗炎性的10,10a-二氢-1H,5H-咪唑并[1,5-b]异喹啉-1,3(2H)-二酮的合成。
J Pharm Sci. 1978 May;67(5):718-9. doi: 10.1002/jps.2600670544.
引用本文的文献
1
Novel 2,5-Diazabicyclo[4.2.0]octanes as GLP-1 Receptor Modulators for Treating Type 2 Diabetes.新型2,5-二氮杂双环[4.2.0]辛烷作为治疗2型糖尿病的胰高血糖素样肽-1受体调节剂
ACS Med Chem Lett. 2023 May 26;14(6):709-710. doi: 10.1021/acsmedchemlett.3c00196. eCollection 2023 Jun 8.
本文引用的文献
1
Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment.重新审视肠促胰岛素和肠内分泌 L 细胞作为 2 型糖尿病治疗靶点的概念。
Pharmacol Res. 2022 Jun;180:106237. doi: 10.1016/j.phrs.2022.106237. Epub 2022 Apr 26.
2
Roles of glucose-dependent insulinotropic polypeptide in diet-induced obesity.葡萄糖依赖性促胰岛素多肽在饮食诱导肥胖中的作用。
J Diabetes Investig. 2022 Jul;13(7):1122-1128. doi: 10.1111/jdi.13816. Epub 2022 May 11.
3
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review.过氧化物酶体增殖物激活受体激动剂、胰高血糖素样肽-1受体激动剂或钠-葡萄糖协同转运蛋白2抑制剂治疗非酒精性脂肪性肝病的疗效：一项系统评价
Lancet Gastroenterol Hepatol. 2022 Apr;7(4):367-378. doi: 10.1016/S2468-1253(21)00261-2. Epub 2022 Jan 12.
4
Peptides in the regulation of glucagon secretion.肽在调节胰高血糖素分泌中的作用。
Peptides. 2022 Feb;148:170683. doi: 10.1016/j.peptides.2021.170683. Epub 2021 Nov 5.
5
Phytochemicals modulate pancreatic islet β cell function through glucagon-like peptide-1-related mechanisms.植物化学物质通过胰高血糖素样肽-1 相关机制调节胰岛 β 细胞功能。
Biochem Pharmacol. 2022 Mar;197:114817. doi: 10.1016/j.bcp.2021.114817. Epub 2021 Oct 27.
6
Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?胰高血糖素样肽-1 在糖尿病治疗中的作用：能否在不引起恶心和呕吐的情况下实现血糖控制？
Br J Pharmacol. 2022 Feb;179(4):542-556. doi: 10.1111/bph.15647. Epub 2021 Sep 14.
Zotero 插件